4.5 Article

A Longitudinal Biomarker for the Extent of Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis

Related references

Note: Only part of the references are listed.
Article Medicine, Research & Experimental

Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients

Lisa M. Rice et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

Review Pharmacology & Pharmacy

Potential value of targeting von Willebrand factor in atherosclerotic cardiovascular disease

Silvia Montoro-Garcia et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2014)

Article Biochemistry & Molecular Biology

Immunoproteasomes Preserve Protein Homeostasis upon Interferon-Induced Oxidative Stress

Ulrike Seifert et al.

Article Biochemistry & Molecular Biology

Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment

Vivian Barry-Hamilton et al.

NATURE MEDICINE (2010)

Article Rheumatology

Myofibroblasts and hyalinized collagen as markers of skin disease in systemic sclerosis

Eugene Y. Kissin et al.

ARTHRITIS AND RHEUMATISM (2006)

Article Biochemical Research Methods

Java Treeview-extensible visualization of microarray data

AJ Saldanha

BIOINFORMATICS (2004)

Article Biochemical Research Methods

Open source clustering software

MJL de Hoon et al.

BIOINFORMATICS (2004)

Article Statistics & Probability

Corrgrams: Exploratory displays for correlation matrices

M Friendly

AMERICAN STATISTICIAN (2002)

Article Immunology

Regulation of the expression of mouse TAP-associated glycoprotein (tapasin) by cytokines

K Abarca-Heidemann et al.

IMMUNOLOGY LETTERS (2002)